FDA 483 - Joseph Thaddeus Beck, MD - October 02, 2020

An FDA inspection of Joseph Thaddeus Beck, MD, a clinical investigator in Springdale, AR, revealed significant deviations from investigational plans and inadequate record-keeping. The inspection found failures in adverse event reporting, subject reconsenting, and adherence to assessment schedules, alongside deficiencies in investigational drug disposition records. These findings indicate a moderate level of non-compliance with clinical trial regulations.